Latest News

William Chey, MD, Explores Integrated Care for IBS Treatment at ACG 2021

1 hour ago

In his lecture, The End of the Beginning: Megatrends in Gastroenterology, William Chey, MD, emphasizes the importance of a multidisciplinary integrated care approach to treating IBS.

Marla C. Dubinsky, MD: Measuring Urgency in Ulcerative Colitis

3 hours ago

An absence of urgency was associated with greater reductions in levels of inflammatory biomarkers C-reactive protein and fecal calprotectin in a cohort of patients treated with mirikizumab.

SER-109 Reduces Recurrence of C Difficile Infections

5 hours ago

Approximately 88% of patients treated with SER-109 achieved a sustained clinical response at 8 weeks.

Jessica R Allegretti, MD, MPH: Preventing Recurrent C Difficile with CP101

5 hours ago

A new study presented at ACG 2021 shows microbiome therapeutic CP101 effective in preventing recurrent CDI by increasing intestinal microbiome diversity.

Etrasimod Leads to Improvements in Quality of Life for Ulcerative Colitis Patients

8 hours ago

Patients in the open-label extension of the OASIS study saw increases in Inflammatory Bowel Disease Questionnaire (IBDQ) scores.

x